Drug Packaging Articles & Analysis
12 news found
Before a new drug enters the market, its manufacturers would voluntarily submit drug master files (DMFs) to regulatory agencies like FDA. The DMFs generally provide confidential information about the manufacture, processing, packaging, and storage of their drug(s). Thus, the production and filing of DMFs has become an important ...
Over the past decade, the CD Formulation’s expert team has made tireless efforts in the research and development of drug delivery systems, trying to improve the pharmacokinetics and pharmacodynamics of drugs. ...
Compared with conventional drugs, nanoparticle-based drug delivery has obvious advantages in terms of stability, biocompatibility, permeability, retention effect, and precise targeting. ...
Though the service portfolio of CD Formulation is far-ranged and nearly covers the whole process of drug formulation, encompassing pre-formulation, formulation, drug analysis, solubility improvement and bioavailability enhancement, packaging, drug delivery system development, one-stop pharmaceutical formulation solution as well ...
Aktiv Pharma Group (Aktiv) announced today the acceptance of its novel glass-free, film-based flexible primary drug container (PDC) technology for sterile injectables named ARCH, into the US Food and Drug Administration (FDA) Emerging Technology Program (ETP). ...
In a recent statement, the US-based CRO company CD Formulation re-demonstrated its competence in drug development and announced that it now offers industry-leading insights, strategies, and practical suggestions on pre-formulation studies for drug developers worldwide. ...
Packaging is another factor that decides the stability and integrity of drugs. ...
Continuing to be a trust-worthy CRO company for drug formulation and development, CD Formulation recently announces the enrichment of its active pharmaceutical ingredient excipient offerings. ...
Carina Biotech is very pleased to announce that we have submitted a pre-IND (Investigational New Drug) application to the US FDA (Food & Drug Administration) for our CAR-T therapy that targets a cancer stem cell antigen known as LGR5. This represents a major step towards taking our CAR-T cell (CNA3103) into a Phase I/IIa clinical trial in patients with ...
Pharmaceutical excipients play magic roles to achieve better drug delivery and adoption. Many challenges can be resolved with the optimal choice of excipients. ...
Drugs must be properly formulated to bring out their best therapeutic effect and at the same time to ease as much administration burden as possible for patients. To select the most suitable dosage form, a lot of factors such as the properties of the drug substance and the project’s commercial needs should be taken into consideration. ...
Luther is a 29-year veteran of the medical device and diagnostics, OTC drugs and consumer-packaged goods industries. ...